.png)
Agenzia Italiana del Farmaco
home
Highlights
-
24 Dec 2025
Companies Section
Guidelines for compiling the dossier of a medicinal product for pricing and reimbursement borne by the NHS
AIFA informs that pursuant to Resolution of the Technical-Scientific Director No. 88/2025 of 23/12/2025, the ‘Guidelines for compiling the dossier supporting the Health Technology Assessment of a medicinal product for the purposes of pricing and reimbursement borne by the National Health Service’ have been updated.
-
19 Dec 2025
The Medicines Utilization Monitoring Centre (OsMed)
Interactive OsMed Now Available - Updated with the Latest Data on Medicine Consumption and Expenditure in Italy
AIFA has launched the updated Interactive OsMed platform, providing online access to analyses from the latest edition of the National Report on Medicines Use in Italy (OsMed Report, 2023–2024, updated as of 26 April 2025). The platform enables users to perform customised queries on medicine use and expenditure indicators at national and regional levels, using dynamic tables, interactive charts, and multi-level comparison tools.
-
19 Dec 2025
Press releases
The first treatment (Skyclarys) for Friedreich's ataxia will be reimbursed by the National Health Service
Seven medicines (including three orphan drugs), two generics and six therapeutic indication extensions have been approved for reimbursement by the AIFA Board of Directors.
-
10 Dec 2025
Independent clinical research
Promoting public research, AIFA invites stakeholders to propose research areas on medicines
AIFA, the first medicines agency in Europe including among its institutional objectives the promotion of scientific research, publishes a survey in order to receive proposals on research needs in the pharmacological field, available until January 30, 2026.
News
15 Jan 2026
Transparency Lists
AIFA updates the Transparency Lists
14 Jan 2026
Companies Section
New Features of the Conference and Meeting Authorisation System
07 Jan 2026
Lists of Class A and Class H medicinal products
List of class A and H medicinal products at 31 July 2025
22 Dec 2025
Monitoring pharmaceutical expenditure
Biosimilar medicines in Italy: AIFA reports updated
19 Dec 2025
Safety of medicinal products
Direct Healthcare Professional Communication (DHPC) on Carbamazepine (Tegretol 100 mg/5ml Oral Suspension)
FarmaciLine
Questions regarding drug efficacy, safety and availability
TOLL-FREE NUMBER
Services
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology
Media
